Cargando…

Aspirin plus ticagrelor or clopidogrel on graft patency one year after coronary bypass grafting: a single-center, randomized, controlled trial

BACKGROUND: Dual antiplatelet therapy (DAPT) improves early post-operative graft patency, but the optimal DAPT strategy for the patients after coronary artery bypass grafting (CABG) has not been confirmed. We sought to evaluate the effect of aspirin plus ticagrelor versus aspirin plus clopidogrel on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Yangfeng, Fan, Xinli, Zhang, Boyao, Zhang, Jiajun, Xue, Qin, Xu, Zhiyun, Han, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024791/ https://www.ncbi.nlm.nih.gov/pubmed/33841960 http://dx.doi.org/10.21037/jtd-20-3407

Ejemplares similares

Clopidogrel versus Ticagrelor for Secondary Prevention after Coronary Artery Bypass Grafting
por: Chang, Hyoung Woo, et al.
Publicado: (2019)

Outcome and Graft Patency in Coronary Artery Bypass Grafting with Coronary Endarterectomy
por: Nemati, Mohammad Hassan, et al.
Publicado: (2015)

Aspirin plus clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: angiographic and clinical results of a randomized study
por: Dalmau, Maria J, et al.
Publicado: (2015)

A Single-Center Bleeding Comparison of Warfarin Plus Aspirin or Clopidogrel Following Coronary Artery Bypass Grafting and Surgical Valve Replacement
por: Zieminski, Joseph J., et al.
Publicado: (2023)

Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study
por: Hansson, Emma C., et al.
Publicado: (2016)

Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery
por: Qu, Jianyu, et al.
Publicado: (2021)

Effect of ticagrelor with or without aspirin on vein graft outcome 1 year after on-pump and off-pump coronary artery bypass grafting
por: Zhu, Yunpeng, et al.
Publicado: (2020)

Comparison of Midterm Outcomes Associated With Aspirin and Ticagrelor vs Aspirin Monotherapy After Coronary Artery Bypass Grafting for Acute Coronary Syndrome
por: Björklund, Erik, et al.
Publicado: (2021)

Aortic distensibility and coronary artery bypass graft patency
por: Özdemir, Bülent, et al.
Publicado: (2009)

Mercaptoalbumin Is Associated with Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting
por: Brioschi, Maura, et al.
Publicado: (2022)

Assessment of the Graft Quality and Patency during and after Coronary Artery Bypass Grafting
por: Masroor, Matiullah, et al.
Publicado: (2023)

Long-term graft patency after coronary artery bypass grafting: Effects of surgical technique
por: Tinica, Grigore, et al.
Publicado: (2019)

The patency of graft and anastomoses in sequential and individual coronary artery bypass grafting: A meta-analysis
por: Li, Yongxing, et al.
Publicado: (2020)

The role of vessel wall physiology in predicting coronary bypass graft patency
por: Singh, Steve K, et al.
Publicado: (2006)

Graft Patency of No-Touch Saphenous Veins Used as Aortocoronary Bypass Grafts
por: Kim, Jeongwon, et al.
Publicado: (2023)

The evolving evidence base for coronary artery bypass grafting and arterial grafting in 2021: How to improve vein graft patency
por: Vervoort, Dominique, et al.
Publicado: (2021)

Long-term graft patency after coronary artery bypass grafting: Effects of morphological and pathophysiological factors
por: Tinica, Grigore, et al.
Publicado: (2018)

Comparison of major bleeding in patients with acute coronary syndrome that underwent coronary artery bypass grafting treated with clopidogrel or ticagrelor: a systematic review and meta-analysis
por: Rohman, Mohammad Saifur, et al.
Publicado: (2020)

About the saphenous vein graft patencies after coronary artery bypass surgery
por: Çakır, Habib, et al.
Publicado: (2019)

Comparison of patency of single and sequential radial artery grafting in coronary artery bypass
por: Kasahara, Hirofumi, et al.
Publicado: (2021)

Optimal Duration for Clopidogrel Suspension Prior to Coronary Artery Bypass Grafting
por: Ullah, Waqas, et al.
Publicado: (2019)

Aspirin/clopidogrel/ticagrelor: Diffuse ooze and bleeding: 2 case reports
Publicado: (2021)

The Value of Inflammation Indexes in Predicting Patency of Saphenous Vein Grafts in Patients With Coronary Artery Bypass Graft Surgery
por: Aydın, Cihan, et al.
Publicado: (2021)

Evaluation of early coronary graft patency after coronary artery bypass graft surgery using multislice computed tomography angiography
por: Bassri, Hosseinali, et al.
Publicado: (2009)

1-Year Patency of Biorestorative Polymeric Coronary Artery Bypass Grafts in an Ovine Model
por: Ono, Masafumi, et al.
Publicado: (2022)

Intraoperative ticagrelor removal via hemoadsorption during on-pump coronary artery bypass grafting
por: Hassan, Kambiz, et al.
Publicado: (2023)

Computed Tomography-Based Angiographic Evaluation of Graft Patency Rate After Coronary Artery Bypass Graft Surgery in Bangladesh
por: Ranjan, Redoy, et al.
Publicado: (2022)

Coronary artery size as a predictor of Y-graft patency following coronary artery bypass surgery
por: Limanto, Danang Himawan, et al.
Publicado: (2021)

Coronary artery bypass graft surgery in patients on ticagrelor therapy is not associated with adverse perioperative outcomes
por: Diab, Sammer, et al.
Publicado: (2021)

Discussion to: Intraoperative ticagrelor removal via hemoadsorption during on-pump coronary artery bypass grafting
Publicado: (2023)

Clopidogrel improves aspirin response after off-pump coronary artery bypass surgery
por: Wang, Xuezhong, et al.
Publicado: (2014)

Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial
por: Wang, Yilong, et al.
Publicado: (2019)

Assessing the Long-term Patency and Clinical Outcomes of Venous and Arterial Grafts Used in Coronary Artery Bypass Grafting: A Meta-analysis
por: Waheed, Abdul, et al.
Publicado: (2019)

Graft patency at 3 months after off- and on-pump coronary bypass surgery: a randomized trial
por: Sajja, Lokeswara Rao, et al.
Publicado: (2019)

COVID-19 - Endothelial Axis and Coronary Artery Bypass Graft Patency: a Target for Therapeutic Intervention?
por: Topal, Gokce, et al.
Publicado: (2020)

Staged repair of chronic type A aortic dissection with small true lumen at the descending aorta
por: Tang, Yangfeng, et al.
Publicado: (2020)

Perioperative aspirin and long-term survival in patients undergoing coronary artery bypass graft
por: Ding, Qian, et al.
Publicado: (2018)

Predictive value of graft patency and major adverse cardiac and cerebrovascular events (MACCEs) in coronary artery bypass grafting (CABG) based on Fourier transform (FFT)
por: Jia, Yanxiong, et al.
Publicado: (2021)

The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
por: Kulik, Alexander, et al.
Publicado: (2005)

Anti-platelet effects of epigallocatechin-3-gallate in addition to the concomitant aspirin, clopidogrel or ticagrelor treatment
por: Joo, Hyung Joon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_iuukasvr24ochg1rdhmb93tcoc